Amgen (NQ:AMGN)

The Dow Jones (^DJI) is made up of 30 of the most established and influential companies in the market. But even blue-chip stocks can struggle - some are dealing with slowing growth, outdated business...

Topics ETFs

1 Dow Jones Stock Worth Your Attention and 2 We Brush Off

December 14, 2025

These dividend growth machines could have considerable upside for long-term investors.

Topics Stocks

2 Dividend Stocks to Double Up on Right Now ↗

December 14, 2025

The American labor market is experiencing a fascinating dichotomy as it navigates late 2024 and 2025. While overall job creation has shown signs of moderation and significant revisions to earlier...

Topics Economy Intellectual Property

Manufacturing Renaissance Fuels Job Market Amidst Shifting Sands

December 09, 2025

The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial...

Topics Artificial Intelligence Economy Electric Vehicles

2 Momentum Stocks for Long-Term Investors and 1 We Brush Off

December 07, 2025

Wondering which stocks are making significant price gaps? Explore the S&P500 index on Friday to find the gap up and gap down stocks in today's session.

Gapping S&P500 stocks in Friday's session ↗

December 05, 2025

Via Chartmill

Breakthrough Therapies Advance as Rare Disease Burden Intensifies Across Aging Populations

December 04, 2025

Via Investor Brand Network

Topics Government

Breakthrough Therapies Advance as Rare Disease Burden Intensifies Across Aging Populations

December 04, 2025

From BioMedWire

Via GlobeNewswire

3 Top ETFs I Plan to Pile Into in December to Boost My Passive Income in 2026 ↗

December 04, 2025

These ETFs can provide me with lots of passive income.

Shares crashed Tuesday on what one analyst called an "overreaction" to the company's prostate cancer treatment update.

Topics ETFs Stocks

Janux Therapeutics Craters 50% On Prostate Cancer Update; Is It An 'Overreaction'? ↗

December 02, 2025

Via Investor's Business Daily

2 Dividend Stocks to Double Up On Right Now ↗

December 01, 2025

Investors don't have to worry about dividend cuts with these two stocks.

The comeback may have begun.

Topics World Trade

5 Healthcare Names to Watch as Sector Rotation Is in Full Swing ↗

December 01, 2025

Via MarketBeat

Should You Buy This Biotech Stock That Just Gained 5% in 1 Day? ↗

November 30, 2025

The Nasdaq 100 (^NDX) is known for housing some of the most innovative and fastest-growing companies in the market. But not every stock in the index is a winner - some are struggling with slowing...

1 Nasdaq 100 Stock Worth Your Attention and 2 We Brush Off

November 25, 2025

The Dow Jones Industrial Average has been on a roller-coaster ride in November 2025, experiencing significant volatility and sending mixed signals across various sectors. While the index achieved a...

Dow Jones Navigates Volatility Amidst AI Bubble Fears and Shifting Fed Expectations

November 25, 2025

The Dow Jones Industrial Average (DJIA) has recently been a barometer of a market caught between conflicting forces, demonstrating significant daily fluctuations throughout November 2025. While the...

Topics Artificial Intelligence Bonds Economy

Dow Jones Navigates Choppy Waters: Rate Cut Hopes Clash with Valuation Fears

November 24, 2025

Q3 Earnings Outperformers: BioMarin Pharmaceutical (NASDAQ:BMRN) And The Rest Of The Therapeutics Stocks

Topics Artificial Intelligence Economy Stocks

November 23, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how therapeutics stocks fared in Q3, starting with BioMarin...

FDA grants accelerated approval to Bayer's Hyrnuo and full approval to Amgen's Imdelltra, expanding treatment options for advanced lung cancer.

Topics Artificial Intelligence

FDA Signs Off On Bayer's New Lung Cancer Drug — Early Results Look Promising ↗

November 20, 2025

Via Benzinga

Which S&P500 stocks are moving before the opening bell on Thursday? ↗

November 20, 2025

Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers.

Via Chartmill

Q3 Earnings Roundup: Myriad Genetics (NASDAQ:MYGN) And The Rest Of The Therapeutics Segment

November 18, 2025

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Myriad Genetics (NASDAQ:MYGN) and its peers.

Tech Stocks Drop, Pharma Gains As Sector Rotation Picks Up: What's Moving Markets Tuesday? ↗

Topics Artificial Intelligence

November 18, 2025

Wall Street endured another wave of selling in tech stocks on Tuesday, with the Nasdaq 100 down more than 1% by midday in New York, extending its month-to-date slide to more than 5%.

Via Benzinga

Check Out What Whales Are Doing With AMGN ↗

November 18, 2025

Via Benzinga

November 17, 2025

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can...

Healthcare stocks have far outperformed the broader market over the past month.

This Sector Is Suddenly Crushing the Broader Market. Should You Invest $1,000? ↗

November 17, 2025

Exchange-traded funds provide investors with exposure to a basket of stocks. Some also pay dividends.

Topics ETFs Government World Trade

These 2 Dividend ETFs Are a Retiree's Best Friend ↗

November 16, 2025

As the broader market concluded with a mixed performance on November 14, 2025, the S&P 500 Healthcare sector once again underscored its often-defensive nature, demonstrating resilience amidst an...

Topics Artificial Intelligence Bonds ETFs

Healthcare Sector Navigates Mixed Market Close: A Beacon of Stability Amidst Uncertainty

November 14, 2025

While AI stocks slide, healthcare is soaring. XLV leads November gains, outperforming tech as investors rotate.

Topics Artificial Intelligence Economy Intellectual Property

Fear Of An AI Bubble? This Sector Is Quietly Surging While Tech Sinks ↗

November 14, 2025

Via Benzinga

Topics Artificial Intelligence

Why Amgen Stock Edged Past the Market on Thursday ↗

November 13, 2025

The pharmaceutical sector mainstay earned several positive mentions in the pundit sphere that day.

As of mid-November 2025, a palpable unease has settled over the technology sector, long the darling of investors and the primary engine of market growth. After a period of unprecedented outperformance,...

Tech Sector Tremors: Is the AI Bubble Deflating, and What's Next for the Market?

November 13, 2025